Maachani UB, Tosi U, Pisapia DJ, Mukherjee S, Marnell CS, Voronina J, Martinez D, Santi M, Dahmane N, Zhou Z et al..
2019.
B7-H3 As a Prognostic Biomarker and Therapeutic Target in Pediatric Central Nervous System Tumors. Transl Oncol. 13(2):365-371.
Chang R, Tosi U, Voronina J, Adeuyan O, Wu LY, Schweitzer ME, Pisapia DJ, Becher OJ, Souweidane MM, Maachani UB.
2019.
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy.. Neurooncol Adv. 1(1):vdz004.
Chang R, Tosi U, Voronina J, Adeuyan O, Wu LY, Schweitzer ME, Pisapia DJ, Becher OJ, Souweidane MM, Maachani UB.
2019.
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy.. Neurooncol Adv. 1(1):vdz004.
Guo H, Kommidi H, Maachani UB, Voronina JC, Zhang W, Magge RS, Ivanidze J, Wu AP, Souweidane MM, Aras O et al..
2019.
An [F]-Positron Emitting Fluorophore Allows Safe Evaluation of Small Molecule Distribution in the CSF, CSF Fistulas, and CNS Device Placement.. Mol Pharm. 16(8):3636-3646.
Wang EW, Zanation AM, Gardner PA, Schwartz TH, Eloy JAnderson, Adappa ND, Bettag M, Bleier BS, Cappabianca P, Carrau RL et al..
2019.
ICAR: endoscopic skull-base surgery.. Int Forum Allergy Rhinol. 9(S3):S145-S365.
Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C et al..
2019.
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.. Nature. 565(7741):654-658.